Faculty Information - IIZUKA Junpei

（Last updated : 2024-04-17 15:32:04）

IIZUKA Junpei
Department School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine Department of Urology

Position Associate Professor

■ Published papers

1.	Original article	Clinical course of candidate renal transplant recipients diagnosed with prostate cancer during pre-transplant screening test. 2024/01
2.	Original article	Renal cell carcinoma outcomes in end-stage renal disease: A 40-year study from two Japanese institutions. 2024/01
3.	Original article	A retrospective cohort study of the impact of peripheral blood gamma- delta T cells to prognosis of nonmetastatic renal cell cancer after curative resection. 2023/12
4.	Original article	A single-center retrospective comparative analysis of urinary continence in robotic prostatectomy with a combination of umbilical ligament preservation and Hood technique. 2023/10
5.	Original article	Predictive factors and oncological outcomes of pathological T3a upstaging in patients with clinical T1 renal cell carcinoma undergoing partial nephrectomy. 2023/10
6.	Original article	Real-world efficacy and safety of cabozantinib following immune checkpoint inhibitor failure in Japanese patients with advanced renal cell carcinoma. 2023/10
7.	Original article	Association between lung immune prognostic index and survival of patients with metastatic urothelial carcinoma treated with pembrolizumab. 2023/07
8.	Original article	Higher risk of intraoperative bleeding in right-sided renal tumors compared to left-sided tumors in robot-assisted partial nephrectomy. 2023/07
9.	Review article	Impact of sex on prognosis in patients with advanced renal cell carcinoma treated with immune checkpoint inhibitors. 2023/07
10.	Case report	Long-time survival of a renal transplant recipient with metastatic mucinous tubular and spindle cell carcinoma: A case report. 2023/05
11.	Original article	Relationship between changes in quality of life and genitourinary toxicity grade after brachytherapy with I-125 alone for localised prostate cancer 2023/03/15
12.	Original article	Comparison of outcomes between therapeutic combinations based on immune checkpoint inhibitors or tyrosine kinase inhibitor monotherapy for first-line therapy of patients with advanced renal cell carcinoma outside of clinical trials: A real-world retrospective multi-institutional study. 2023/03
13.	Original article	Efficacy of combined pembrolizumab and pelvic radiotherapy for bladder cancer with rectal metastases. 2023/03
14.	Original article	Impact of warm ischemia on acute kidney injury after robotic partial nephrectomy stratified by baseline kidney function. 2023/03
15.	Original article	Impact of body mass index on outcomes in an asian population of advanced renal cell carcinoma and urothelial carcinoma treated with immune checkpoint inhibitors. 2023/02
16.	Original article	Comparison of the impact of immune-related adverse events due to immune checkpoint inhibitor dual combination therapy and immune checkpoint inhibitor plus tyrosine kinase inhibitor combination therapy in patients with advanced renal cell carcinoma. 2023/01
17.	Original article	Analyses of operative time according to procedure phases during robot-assisted laparoscopic partial nephrectomy using the iPhone application “My Intuitives” 2022/11
18.	Original article	Outcomes of nivolumab monotherapy for previously treated metastatic renal cell carcinoma: a real-world multi-institution data with a minimum of 2 years of follow-up. 2022/07/08
19.	Original article	Efficacy and Safety of Immunotherapy-Based Combinations as First-Line Therapy of Metastatic Renal Cell Carcinoma in Patients Who Do Not Meet Trial Eligibility Criteria 2022/07/05
20.	Original article	New longitudinal component of the RENAL nephrometry score for predicting the operative complexity in transperitoneal robot-assisted partial nephrectomy. 2022/06
21.	Original article	Surgical outcomes of robot-assisted laparoscopic partial nephrectomy for cystic renal cell carcinoma. 2022/06
22.	Original article	Antibody response to SARS-CoV-2 mRNA vaccine among kidney transplant recipients: A retrospective cohort study at a single transplant institute in Japan. 2022/05
23.	Original article	Predictive impact of early changes in serum C-reactive protein levels in nivolumab plus ipilimumab therapy for metastatic renal cell carcinoma. 2022/02
24.	Original article	Efficacy and safety of immune checkpoint inhibitors in elderly patients with metastatic renal cell carcinoma. 2022/01
25.	Original article	Antibiotic use and survival of patients receiving pembrolizumab for chemotherapy-resistant metastatic urothelial carcinoma 2021/12
26.	Original article	Association of tumor burden with outcome in first-line therapy with nivolumab plus ipilimumab for previously untreated metastatic renal cell carcinoma. 2021/12
27.	Original article	Hypopituitarism in patients with metastatic renal cell carcinoma treated with ipilimumab and nivolumab combination therapy. 2021/12
28.	Original article	Limited impact of warm ischemic threshold for partial nephrectomy in the robotic surgery era: A propensity score matching study. 2021/12
29.	Original article	Association between ureteral clamping time and acute kidney injury during robot-assisted radical cystectomy. 2021/11
30.	Original article	Three cases of nivolumab plus ipilimumab therapy in haemodialysis patients with metastatic renal cell carcinoma. 2021/11
31.	Original article	Comparable survival outcome between acquired cystic disease associated renal cell carcinoma and clear cell carcinoma in patients with end-stage renal disease: a multi-institutional central pathology study. 2021/10
32.	Original article	Greater renal function benefit from enucleation technique for more complex renal tumors in robot-assisted partial nephrectomy. 2021/10
33.	Original article	Prognostic impact of immune-related adverse events in metastatic renal cell carcinoma treated with nivolumab plus ipilimumab. 2021/10
34.	Original article	Surgery for renal cell carcinoma extending to the right atrium in Japanese institutions: Focusing on cardiopulmonary bypass with or without deep hypothermic circulatory arrest. 2021/10
35.	Original article	Albumin-to-alkaline phosphatase ratio as a novel prognostic marker of nivolumab monotherapy for previously treated metastatic renal cell carcinoma. 2021/09
36.	Original article	Prognostic impact of trial-eligibility criteria in patients with metastatic renal cell carcinoma 2021/08
37.	Original article	Prognostic impact of early treatment interruption of nivolumab plus ipilimumab due to immune-related adverse events as first-line therapy for metastatic renal cell carcinoma: A multi-institution retrospective study. 2021/07
38.	Original article	Outcome of advanced renal cell carcinoma arising in end-stage renal disease: comparison with sporadic renal cell carcinoma. 2021/06
39.	Case report	Robot-assisted laparoscopic partial nephrectomy for allograft renal cell carcinoma: A case report. 2021/06
40.	Original article	Assessing improvements in metastatic renal cell carcinoma systemic treatments from the pre-cytokine to the immune checkpoint inhibitor eras: a retrospective analysis of real-world data. 2021/05
41.	Original article	Impact of sarcopenia on post-operative outcomes following nephrectomy and tumor thrombectomy for renal cell carcinoma with inferior vena cava thrombus. 2021/04
42.	Original article	Modest efficacy of nivolumab plus ipilimumab in patients with papillary renal cell carcinoma. 2021/04
43.	Original article	Therapeutic benefit of lymphadenectomy for older patients with urothelial carcinoma of the upper urinary tract: a propensity score matching study. 2021/04
44.	Original article	A novel prognostic model for Japanese patients with newly diagnosed bone-metastatic hormone-naïve prostate cancer. 2021/03
45.	Original article	Predictive impact of prognostic nutritional index on pembrolizumab for metastatic urothelial carcinoma resistant to platinum-based chemotherapy. 2021/03
46.	Original article	Predictive role of γ‑glutamyltransferase in patients receiving nivolumab therapy for metastatic renal cell carcinoma. 2021/03
47.	Original article	The controlling nutritional status CONUT score in patients with advanced bladder cancer after radical cystectomy. 2021/03
48.	Original article	Comparisons of surgical outcomes between transperitoneal and retroperitoneal approaches in robot-assisted laparoscopic partial nephrectomy for lateral renal tumors: a propensity score-matched comparative analysis. 2021/02
49.	Original article	Detection of a peritumoral pseudocapsule in patients with renal cell carcinoma undergoing robot‑assisted partial nephrectomy using enhanced MDCT. 2021/01
50.	Original article	Efficacy of nivolumab versus molecular-targeted therapy as second-line therapy for metastatic renal cell carcinoma: Real-world data from two Japanese institutions. 2021/01
51.	Original article	Prognostic impact of metastasectomy in renal cell carcinoma in the postcytokine therapy era. 2021/01
52.	Case report	Total nephroureterocystectomy and urethrectomy due to urothelial carcinoma associated with the BK polyomavirus infection after kidney transplantation: a case report with literature review. 2020/11
53.	Original article	Clinical outcomes of repeat partial nephrectomy compared to initial partial nephrectomy of a solitary kidney. 2020/06
54.	Original article	Efficacy of axitinib after nivolumab failure in metastatic renal cell carcinoma. 2020/05
55.	Original article	Predictive factors for recurrence after partial nephrectomy for clinical T1 renal cell carcinoma: a retrospective study of 1227 cases from a single institution. 2020/05
56.	Original article	Computed tomography imaging characteristics of clear cell papillary renal cell carcinoma. 2020/01
57.	Original article	Negative effect of immediate sunitinib interruption on survival in patients with metastatic renal cell carcinoma. 2019/11
58.	Original article	Predictive Impact of Peripheral Blood Markers and C-Reactive Protein in Nivolumab Therapy for Metastatic Renal Cell Carcinoma. 2019/08
59.	Original article	Association between tumor contact surface area and parenchymal volume change in robot-assisted laparoscopic partial nephrectomy carried out using the enucleation technique. 2019/07
60.	Original article	Outcomes, complications, and economic impact of ABO-incompatible living kidney transplantation: A single‐center Japanese cohort study. 2019/06
61.	Original article	Correlation between the magnitude of best tumor response and patient survival in nivolumab therapy for metastatic renal cell carcinoma. 2019/04
62.	Original article	Peritumoral pseudocapsule status according to pathological characteristics from robot-assisted laparoscopic partial nephrectomy for localized renal cell carcinoma. 2019/04
63.	Original article	Prognostic markers for refined stratification of IMDC intermediate-risk metastatic clear cell renal cell carcinoma treated with first-line tyrosine kinase inhibitor therapy. 2019/04
64.	Original article	Assessment of postoperative renal function after adrenalectomy in patients with primary aldosteronism. 2019/02
65.	Original article	Effect of changes in skeletal muscle mass on oncological outcomes during first-line sunitinib therapy for metastatic renal cell carcinoma. 2018/12
66.	Original article	Once-daily vs twice-daily tacrolimus for de novo living kidney transplantation patients including ABO/HLA compatible and incompatible:A randomized trial. 2018/12
67.	Original article	Acquired cystic disease-associated renal cell carcinoma is the most common subtype in long-term dialyzed patients: Central pathology results according to the 2016 WHO classification in a multi-institutional study. 2018/10
68.	Original article	Follow-up Survey of Donor Candidates for Living Related Kidney Transplantation With Prostate Cancer. 2018/10
69.	Original article	Immediate progressive disease in patients with metastatic renal cell carcinoma treated with nivolumab: a multi-institution retrospective study. 2018/10
70.	Original article	Impact of the Mayo Adhesive Probability Score on the Complexity of Robot-Assisted Partial Nephrectomy. 2018/10
71.	Original article	Radical Prostatectomy for Localized Prostate Cancer in Renal Transplant Recipients: 13 Cases Studied at a Single Center. 2018/10
72.	Original article	Durable response after discontinuation of nivolumab therapy in patients with metastatic renal cell carcinoma. 2018/09
73.	Original article	Outcome of the risk-stratified desensitization protocol in donor-specific antibody-positive living kidney transplant recipients: a retrospective study. 2018/09
74.	Original article	Efficacy and safety of third-line molecular-targeted therapy in metastatic renal cell carcinoma resistant to first-line vascular endothelial growth factor receptor tyrosine kinase inhibitor and second-line therapy. 2018/06
75.	Original article	Evaluation of relative dose intensity during the early phase of first-line sunitinib treatment using a 2-week-on/1-week-off regimen for metastatic renal cell carcinoma. 2018/06
76.	Original article	Prognostic impact of the components of progressive disease on survival after first-line tyrosine kinase inhibitor therapy for metastatic renal cell carcinoma. 2018/06
77.	Original article	Evaluation of renal function change during first-line tyrosine kinase inhibitor therapy for metastatic renal cell carcinoma. 2017/12
78.	Case report	Intensity-modulated radiation therapy for small cell carcinoma of the prostate: A case report 2017/09/01
79.	Original article	Preoperative controlling nutritional status (CONUT) score as a novel predictive biomarker of survival in patients with localized urothelial carcinoma of the upper urinary tract treated with radical nephroureterectomy. 2017/09
80.	Original article	Time to progression after first-line tyrosine kinase inhibitor predicts survival in patients with metastatic renal cell carcinoma receiving second-line molecular-targeted therapy. 2017/09
81.	Original article	Limited benefit of targeted molecular therapy for inferior vena cava thrombus associated with renal cell carcinoma. 2017/08
82.	Original article	The 5-year outcomes of moderately hypofractionated radiotherapy (66Gy in 22 fractions, 3 fractions per week) for localized prostate cancer: a retrospective study 2017/07
83.	Original article	Evaluation of tumor burden after sequential molecular-targeted therapy in patients with metastatic renal cell carcinoma. 2017/03
84.	Original article	Effect of the timing of best tumor shrinkage on survival of patients with metastatic renal cell carcinoma who received first-line tyrosine kinase inhibitor therapy. 2017/02
85.	Original article	Sarcopenia predicts survival outcomes among patients with urothelial carcinoma of the upper urinary tract undergoing radical nephroureterectomy: a retrospective multi-institution study. 2017/02
86.	Original article	Surgical and Oncologic Outcomes of Laparoscopic Radical Nephrectomy for Non-Metastatic Renal Cancer in Long-Term Dialysis Patients. 2017/02
87.	Original article	Template-based lymphadenectomy reduces the risk of regional lymph node recurrence among patients with upper/middle ureteral cancer. 2017/02
88.	Original article	Template-based lymphadenectomy reduces the risk of regional lymph node recurrence among patients with upper/middle ureteral cancer. 2017/02
89.	Original article	A propensity score-matched comparison of surgical precision obtained by using volumetric analysis between robot-assisted laparoscopic and open partial nephrectomy for T1 renal cell carcinoma: a retrospective non-randomized observational study of initial outcomes. 2016/10
90.	Original article	Sarcopenia and the modified glasgow prognostic score are significant predictors of survival among patients with metastatic renal cell carcinoma who are receiving first-line sunitinib treatment. 2016/10
91.	Original article	Comparison of progression to end-stage renal disease requiring dialysis after partial or radical nephrectomy for renal cell carcinoma in patients with severe chronic kidney disease. 2016/09
92.	Original article	Late recurrence of a malignant hypoglycemia-inducing pelvic solitary fibrous tumor secreting high-molecular-weight insulin-like growth factor-II: A case report with protein analysis. 2016/07
93.	Original article	Use of mammalian target of rapamycin inhibitors after failure of tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma undergoing hemodialysis: A single-center experience with four cases. 2016/07
94.	Original article	Comparison of survival rates in stage 1 renal cell carcinoma between partial nephrectomy and radical nephrectomy patients according to age distribution: a propensity score matching study. 2016/06
95.	Original article	The magnitude of best tumor shrinkage during second-line targeted therapy affects progressionfree survival but not overall survival in patients with metastatic renal cell carcinoma. 2016/06
96.	Case report	Efficacy and Feasibility of Intensity-Modulated Radiation Therapy for Prostate Cancer in Renal Transplant Recipients 2016/04/01
97.	Original article	Efficacy and feasibility of low-dose rate brachytherapy for prostate cancer in renal transplant recipients. 2016/04/01
98.	Original article	Robot-assisted radical prostatectomy for localized prostate cancer in asian renal transplant recipients. 2016/04
99.	Original article	The magnitude of best tumor shrinkage during second-line targeted therapy affects progression-free survival but not overall survival in patients with metastatic renal cell carcinoma. 2016/03
100.	Original article	Efficacy and safety of sorafenib for treatment of Japanese metastatic renal cell carcinoma patients undergoing hemodialysis. 2016/02
101.	Original article	Early unclamping might reduce the risk of renal artery pseudoaneurysm after robot-assisted laparoscopic partial nephrectomy. 2015/12
102.	Other	Possible impact of continuous drainage after minimally invasive partial nephrectomy. 2015/11
103.	Original article	Comparison of prognosis between patients with renal cell carcinoma on hemodialysis and those with renal cell carcinoma in the general population. 2015/10
104.	Original article	Assessment of surgical outcomes of the non-renorrhaphy technique in open partial nephrectomy for ≥T1b renal tumors. 2015/09
105.	Case report	Fat-poor angiomyolipoma with cyst-like changes mimicking a cystic renal cell carcinoma: a case report. 2015/08
106.	Original article	Clinical and pathological analyses of chronic vascular rejection after kidney transplantation. 2015/07
107.	Case report	Combination of molecular targeted therapy and surgery for a patient with metastatic renal cell carcinoma with a poor prognosis. 2015/07
108.	Original article	Renal sinus exposure as an independent factor predicting asymptomatic unruptured pseudoaneurysm formation detected in the early postoperative period after minimally invasive partial nephrectomy. 2015/04
109.	Original article	High prevalence of the MYD88 mutation in testicular lymphoma:immunohistochemical and genetic analyses 2015
110.	Original article	Possible role of template-based lymphadenectomy in reducing the risk of regional node recurrence after nephroureterectomy in patients with renal pelvic cancer. 2014/12
111.	Original article	Clinical symptoms predict poor overall survival in chronic-dialysis patients with renal cell carcinoma associated with end-stage renal disease. 2014/11
112.	Original article	Better recovery of kidney function in patients with de novo chronic kidney disease after partial nephrectomy compared with those with pre-existing chronic kidney disease. 2014/06
113.	Original article	Template-based lymphadenectomy in urothelial carcinoma of the renal pelvis: A prospective study. 2014/05
114.	Case report	Cystic local recurrence of renal cell carcinoma after laparoscopic radical nephrectomy in a hemodialysis patient. 2014/03
115.	Original article	Superior Tolerability of Altered Dosing Schedule of Sunitinib with 2-Weeks-on and 1-Week-off in Patients with Metastatic Renal Cell Carcinoma-Comparison to Standard Dosing Schedule of 4-Weeks-on and 2-Weeks-off 2014/03
116.	Original article	Mannitol has no impact on renal function after open partial nephrectomy in solitary kidneys 2014/02
117.	Original article	The influence of RENAL nephrometry score on pre-ruptured pseudoaneurysm formation detected by computed tomography angiography in early postoperative period after minimally invasive partial nephrectomy. 2014/01
118.	Original article	The utility of monitoring serum KL-6 level for predicting the onset of mTOR inhibitors induced interstitial lung disease 2013/07
119.	Original article	Comparison of Survival Rates in Patients with Metastatic Renal Cell Carcinoma According to Treatment Era Including Cytokine and Targeted Therapy 2013/04
120.	Original article	Negative impact of papillary histological subtype in patients with renal cell carcinoma extending into the inferior vena cava: Single-center experience 2013
121.	Original article	Similar functional outcomes after partial nephrectomy for clinical T1b and T1a renal cell carcinoma 2012/11
122.	Original article	Cytoreductive nephrectomy for pT3b-T4 M1 renal cell carcinoma in 39 patients: single center analysis 2012/09
123.	Original article	Predictors for postoperative renal function after open partial nephrectomy: Including postoperative biomarkers 2012/09
124.	Original article	Prognosis and characteristics of renal cell carcinoma in hemodialysis patients: Bilateral occurrence does not influence cancer-specific survival 2011/12
125.	Original article	Decompressive surgery in combination with preoperative transcatheter arterial embolization: Successful improvement of ambulatory function in renal cell carcinoma patients with metastatic extradural spinal cord compression 2011/10
126.	Original article	Analysis of laparoscopic radical nephrectomy for renal cell carcinoma patients with end stage kidney disease requiring hemodialysis 2011/09
127.	Original article	Postoperative renal function after partial nephrectomy for renal cell carcinoma in patients with pre-existing chronic kidney disease: a comparison with radical nephrectomy 2011/06
128.	Original article	Clinical results and pharmacokinetics of sorafenib in chronic hemodialysis patients with metastatic renal cell carcinoma in a single center 2011/05
129.	Original article	Presurgical targeted therapy with tyrosine kinase inhibitors for advanced renal cell carcinoma: clinical results and histopathological therapeutic effects. 2010/12
130.	Original article	Contralateral metachronous tumor occurrence is more frequently associated with distant metastases or postoperative intrarenal recurrence in renal cell carcinoma patients 2010/07
131.	Original article	Presurgical targeted therapy with tyrosine kinase inhibitors for advanced renal cell carcinoma: clinical results and histopathological therapeutic effects. 2010
132.	Original article	Template-based lymphadenectomy in urothelial carcinoma of the upper urinary tract: Impact on patient survival. 2010
133.	Original article	Persistent subclinical rejection associated with nodular B-cell infiltrates in a renal transplant recipient 2008/07
Display 5 items
Display all(133)

■ Academic conference presentation

1.	Follow-up survey of candidate renal transplant recipients with prostate cancer diagnosed during the pre-transplant screening test. 2023/08/25
2.	A case of renal transplantation with CAAMR revealed by a novel HLA antibody approach. 2023/04/29
3.	Comparison of the impacts of immune-related adverse events on the prognosis of patients with advanced renal cell carcinoma between patients treated with IO-IO and IO-TKI combination therapy.. 2023/04/29
4.	Outcome change in patients with advanced renal celcarcinoma outside of clinicalal trials from the tyrosine-kinase inhibitor era to the immune checkpoint inhibitor era. 2023/04/29
5.	Prognostic factors for recurrence after robot-assisted laparoscopic partial nephrectomy： Real-world data from Japanese single high-volume center. 2023/04/29
6.	Validation of predictive model for new baseline renal function after radical nephrectomy or robot-assisted partial nephrectomy in Japanese patients. 2023/04/29
7.	Initial experiences of robot-assisted adrenalectomy. 2023/04/22
8.	Medication states of up-front ARAT treatment for mHSPC in real-world practice. 2023/04/21
9.	Prognostic factors for recurrence after robot-assisted laparoscopic partial nephrectomy: Real-world data from Japanese single high-volume center. 2023/04/21
10.	Circulation kinetics analysis using computed tomography of papillary renal cell carcinoma, chromophobe renal cell carcinoma, oncocytoma, and angiomyolipoma. 2023/04/20
11.	Donor-derived cell-free DNA analysis is capable of detecting antibody-mediated rejection in one-year biopsy of kidney allograft. 2023/04/20
12.	Higher risk of intraoperative bleeding in right-sided renal tumors compared to left-sided tumors in robot-assisted partial nephrectomy. 2023/04/20
13.	Impact of warm ischemia on acute kidney injury after robotic partial nephrectomy stratified by baseline kidney function. 2023/04/20
14.	Outcome in patients with advanced renal cell carcinoma treated with immunotherapy vs. tyrosine kinase inhibitor based on the status of chronic kidney disease. 2023/04/20
15.	Influence of HLA epitope mismatch on the kidney allograft after transplantation. 2022/11/26
16.	Outcomes of treatments for acute antibody-mediated rejection after kidney transplantation. 2022/11/26
17.	Antibody responses to BNT162b2 booster in kidney transplant recipients vacci‐nated twice. 2022/10/24
18.	Surgical outcomes for older patients with renal cell carcinoma and inferior vena cava thrombus. 2022/05/16
19.	Efficacy and feasibility of robot-assisted partial nephrectomy for octogenarians: Comparison with younger counterparts. 2022/05/15
20.	Order of thrombectomy for management of renal cell carcinoma with inferior vena cava thrombus. 2022/05/15
21.	Association between immune adverse events and survival of patients with metastatic urothelial carcinoma treated with pembrolizumab. 2022/05/13
22.	Association between ureteral clamping time and acute kidney injury during robot-assisted radical cystectomy. 2022/05/13
23.	C-reactive protein kinetics to predict recurrence after radical surgery for high-risk renal cell carcinoma. 2022/05/13
24.	Effects of first-line immune checkpoint inhibitors in patients with metastatic renal cell carcinoma not meeting trial eligibility criteria. 2022/05/13
25.	Potential survival benefit of deferred nephrectomy in patients treated with nivolumab plus ipilimumab for metastatic renal cell carcinoma. 2022/05/13
26.	Predictive impact of early changes in serum c-reactive protein levels in nivolumab plus ipilimumab therapy for metastatic renal cell carcinoma. 2022/05/13
27.	Retzius-sparing robot-assisted radical prostatectomy in a renal transplant recipient. 2021/07/25
28.	Medication adherence and treatment outcome in patients with metastatic castration-resistant prostate cancer receiving enzalutamide. 2020/12/24
29.	A new predictive model for prognosis in oligometastatic prostate cancer. 2020/12/23
30.	Association between controlling nutritional status（CONUT）score and outcomes after radical cystectomy for advanced bladder cancer. 2020/12/23
31.	Association between early tumor response and survival in metastatic renal cell carcinoma treated with nivolumab. 2020/12/23
32.	Comparison of efficacy and safety between second-line and later-line nivolumab therapy for metastatic renal cell carcinoma. 2020/12/23
33.	The predictive impact of presurgical sarcopenia on patient survival in patients with renal cell carcinoma with inferior vena cava tumor thrombus. 2020/12/23
34.	Therapeutic benefit of lymphadenectomy during radical nephroureterectomy for elderly patients with upper tract urothelial carcinoma. 2020/12/23
35.	Reduced risk of new occurrence or progression of sarcopenia by robot-assisted radical cystectomy compared to the open procedure. 2020/12/22
36.	Retroperitoneal approach is better quality of recovery than transperitoneal approach after robot-assisted partial nephrectomy. 2020/12/22
37.	Trifecta outcomes of robot-assisted laparoscopic partial nephrectomy compared to conventional partial nephrectomy. 2020/12/22
38.	The 34th Congress of Japanese Society of Endourology 2020/11/19
39.	Comparisons of surgical outcomes between transperitoneal and retroperitoneal　approaches in robot-assisted laparoscopic partial nephrectomy for lateral renal tumors: A propensity score-matched comparative analysis. 2020/07/17
40.	Detection of a peritumoral pseudocapsule in patients with renal cell carcinoma undergoingrobot-assisted partial nephrectomy, using enhanced CT. 2020/07/17
41.	Predictive factors for recurrence after complete metastasectomy in patients with metastaticrenal cell carcinoma in the targeted therapy era. 2020/07/17
42.	Usefulness of robot-assisted laparoscopic partial nephrectomy using trifecta criteria. 2020/07/17
43.	Correlation between the changes in the EPIC QOL score and the grading of genitourinary toxicity after permanent prostate brachytherapy with I-125 alone for prostate cancer 2019/10/25
44.	Renal cell carcinoma in end-stage renal disease exhibits specific molecular alterations corresponding to their histopathology. 2019/10/18
45.	Renal cell carcinoma in end-stage renal disease has specific molecular alterations corresponding to the histopathology. 2019/09/27
46.	Clinical future of mucinous tubular and spindle cell carcinoma of the kidney. 2019/08/17
47.	Prostate imaging reporting and data system score before prostate biopsy can predict biochemical recurrence in patients with prostate cancer treated with radiotherapy. 2019/05/06
48.	Association between tumor contact surface area and parenchymal volume change in robot-assisted laparoscopic partial nephrectomy performed using the enucleation technique. 2019/05/04
49.	Effect of changes in skeletal muscle mass on oncological outcomes during first-line sunitinib herapy for metastatic renal cell carcinoma. 2019/05/04
50.	Long-term follow-up of renal function and development of chronic kidney disease after partial nephrectomy. 2019/05/04
51.	Presence of peritumoral pseudocapsules detected based on findings from robot-assisted laparoscopic partial nephrectomy for localized renal cell carcinoma. 2019/05/04
52.	Association of immune-related adverse events with prognosis in patients with metastatic renal cell carcinoma treated with nivolumab. 2019/05/03
53.	Detection of a peritumoral pseudocapsule in patients with renal cell carcinoma undergoing robot-assisted partial nephrectomy, using enhanced CT. 2019/05/03
54.	Combined androgen blockade as first-line therapy for men with high-risk metastatic hormone-naïve prostate cancer. 2018/10/20
55.	Robotic surgeries for urological malignancies in renal transplant recipients 2018/10/05
56.	Effect of luteinizing hormone-eleasing hormone antagonist on testosterone recovery after neoadjuvant therapy with or without adjuvant androgen deprivation and radiotherapy for localized prostate cancer. 2018/05/21
57.	Superior efficacy of degarelix as neoadjuvant hormone therapy in control of acute genitourinary toxicity associated with radiation therapy for prostate cancer compared to LHRH agonist; A propensity-score matching analysis. 2018/05/21
58.	Clinicopathological analysis of prostate cancer in patients with renal transplant recipients. 2018/05/20
59.	Effect of early-period relative dose intensity in first-line sunitinib therapy with a 2-weeks-on and 1-week-off regimen for metastatic renal cell carcinoma. 2018/05/20
60.	Comparison of kidney function in the early postoperative period between a transperitoneal versus retroperitoneal robot-assisted laparoscopic partial nephrectomy for posterior renal tumor : A propensity score-matched study. 2018/05/19
61.	Post Adrenalectomy renal function in patients with primary aldosteronism. 2018/05/18
62.	Predictive factors for immediate progression after nivolumab therapy for metastatic renal cell carcinoma. 2018/04/20
63.	Usefulness of the modified Glasgow Prognostic Score (mGPS) in patients with castration- sensitive prostate cancer: muti- institutional study. 2018/04/19
64.	Redical Prostatectomy for Localized Prostate Cancer in Renal Transplant Recipients:13 Cases Studied at a Single Center 2017/11/28
65.	High dose rate brachytherapy with hypofractionated external beam radiotherapy for high-risk prostate cancer 2017/09/25
66.	The 5-year outcomes of moderately hypofractionated radiotherapy for localized prostate cancer. 2017/09/25
67.	Prostate imaging reporting and data system score before prostate biopsy can predict biochemical recurrence in patients with prostate cancer treated with radiotherapy. 2017/08/19
68.	Higher risk of recurrence at extraregional nodes after radical nephroureterectomy in patients with left than in patients with right ureteral cancer 2017/05/15
69.	Clinicopathological characteristics of patients with acquiredcystic disease-associated renal cell carcinoma: Central pathology results according to the 2016 WHO classification in a multi-institutional study 2017/05/14
70.	Clinicopathological characteristics of the patients with acquired-cystic disease-associated renal cell carcinoma according to 2016 WHO classification. 2017/04/21
71.	Usefulness of multiparametric MRI in prognosis for high risk prostate cancer after radiotherapy. 2017/04/21
72.	Impact of surgeon's experience on occurrence of renal artery pseudoaneurysm after robot-assisted laparoscopic partial nephrectomy. 2016/11/11
73.	Comparison of surgical and oncologic outcomes between long-term and short-term dialysis patients undergoing laparoscopic radical nephrectomy for non-metastatic renal cancer. 2016/11/09
74.	Efficacy and feasibility of radiotherapy for localized prostate cancer in renal transplant recipients: a single-center experience. 2016/08/20
75.	Risk factors for asymptomatic renal artery pseudoaneurysm after partial nephrectomy detected by enhanced CT in the early postoperative period. 2016/05/09
76.	Assessment of surgical outcomes of the non-renorrhaphy technique in open partial nephrectomy for =T1B renal tumors. 2016/05/08
77.	Association of preoperative proteinuria with renal functional outcomes after open partial nephrectomy in patients with an anatomically or functionally solitary kidney. 2016/05/08
78.	Comparison of perioperative outcomes with or without renorrhaphy in open partial nephrectomy: A propensity score-matched study. 2016/05/08
79.	Preoperative prostate imaging reporting and data system score: An independent predictor of positive surgical margin after robot-assisted radical prostatectomy. 2016/05/08
80.	Sarcopenia and the modified glasgow prognostic score are significant predictors of patient survival in metastatic renal cell carcinoma patients receiving first-line sunitinib treatment. 2016/05/07
81.	Prostate imaging reporting and data system score before prostate biopsy can predict biochemical failure in prostate cancer patients treated with high-dose-rate brachytherapy. 2016/05/06
82.	Better preservation of renal function after robotic partial nephrectomy is associated with lower volume loss compared with laparoscopic partial nephrectomy. 2016/04/25
83.	Lymphatic metastases from the urothelial carcinoma of the left lower ureter spreads more extensively at higher incidence than the tumors of the right side. 2016/04/24
84.	Outcome and toxicities of high-dose rate brachytherapy combined with hypofractionated external beam radiation therapy for high-risk prostate cancer 2016/04
85.	Comparison of perioperative outcomes with or without renorrhaphy in open partial nephrectomy: A propensity score-matched study. 2016/03/14
86.	Risk factors for asymptomatic renal artery pseudoaneurysm after partial nephrectomy detected by enhanced CT in the early postoperative period. 2016/03/14
87.	Association between better renal function preservation and lower volume loss between robotic partial nephrectomy and laparoscopic partial nephrectomy: A propensity score matched analysis. 2016/03/13
88.	Use of mammalian target of rapamycin inhibitors after failure of tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma undergoing hemodialysis: A single-center experience. 2015/10/30
89.	Early unclamping technique significantly increases the probability of achieving pentafecta after robot-assisted laparoscopic partial nephrectomy. 2015/10/03
90.	endGIA decreased Positive Margin of Apex in Laparoscopic Radical Prostatectomy. 2015/10/02
91.	Efficacy and feasibility of intensity-modulated radiation therapy for prostate cancer in renal-transplant recipients. 2015/08/26
92.	Efficacy and feasibility of low-dose brachytherapy for prostate cancer in renal-transplant recipients. 2015/08/26
93.	Robot-assisted radical prostatectomy in renal transplant recipients: the first report in asian patient. 2015/08/26
94.	The clinical benefit of metastasectomy in metastatic renal cell carcinoma in the era of targeted molecular therapy. 2015/05/18
95.	The relationship between the timing of maximum tumor shrinkage during 1st-line targeted therapy and overall survival of patients with metastatic renal cell carcinoma. 2015/05/18
96.	Comparison of survival rates in stage one renal cell carcinoma between partial nephrectomy and radical nephrectomy patients according to age distribution. 2015/05/17
97.	Template-based lymphadenectomy reduces the risk of regional lymph node recurrence in patients with upper/middle ureteral cancer. 2015/05/15
98.	Hypofractionated image guided-IMRT for clinically localized prostate cancer. 2014/09/14
99.	Template-based lymphadenectomy reduced the risk of regional node recurrence in patients with renal pelvic cancer. 2014/05/20
100.	Limited benefit of targeted therapies on ivc thrombus in renal cell carcinoma. 2014/05/19
101.	Risk factors and management of unruptured renal artery pseudoaneurysms immediately after laparoscopic partial Nephrectomy. 2014/05/19
102.	Advantages of transperitoneal approach over retroperitoneal approach in laparoscopic radical nephrectomy for renal cancer in patients with dialysis-dependent, end-stage renal disease 2013/09/09
103.	Impact Of Preoperative C-Reactive Protein On Survival Of Patients On Chronic Hemodialysis Undergoing Nephrectomy For Renal Cell Carcinoma 2013/08/31
104.	The Clinical Benefit of Targeted Therapies On IVC Thrombus Of Renal Cell Carcinoma 2013/08/31
105.	Better recovery of kidney function in patients with de novo chronic kidney disease after partial nephrectomy compared with those with pre-existing chronic kidney disease 2013/05/20
106.	Usefulness of temporary inferior vena cava filter in preventing intraoperative pulmonary embolism for patients with renal cell carcinoma extending into inferior vena cava thrombus 2013/05/07
107.	Better kidney functional recovery in patients with de novo CKD after partial nephrectomy compared to those with pre-existing CKD 2013/05/06
108.	Enhanced CT after partial nephrectomy in early postoperative period to detect asymptomatic renal artery pseudoaneurysm 2013/05/06
109.	Therapeutic benefit from template-based lymphadenectomy in urothelial carcinoma of the renal pelvis - Multi-institutional prospective study - 2013/05/06
110.	Therapeutic benefit from template-based lymphadenectomy in urothelial carcinoma of the renal pelvis 2013/03/18
111.	Analysis of factors associated with perioperative outcomes in patients with dialysis-dependent end-stage renal disease undergoing laparoscopic radical nephrectomy 2013/02/09
112.	Anatomic complexity quantitated by nephrometry score ssociated with kidney function after partial nephrectomy 2013/02/08
113.	Impact of RENAL nephrometry Score on Renal Function after Partial Nephrectomy in Solitary Kidneys 2012/10/01
114.	No Impact of Mannitol on Renal Function after Partial Nephrectomy in Solitary Kidneys 2012/10/01
115.	Safty of Partial Nephrectomy for Patients on Chronic Anticoagulant Therapy 2012/10/01
116.	Comparison of Survival Rates in Patients with Metastatic Renal Cell Carcinoma According to the ERA Including PRE-Cytokine,Cytokine and Targeted Therapy 2012/08/18
117.	No Impact of Mannitol on Renal Function after Partial Nephrectomy in Solitary Kidneys 2012/08/18
118.	Significant Negative Impact of Papillary Histological Subtype in Patients with Renal Cell Carcinoma Extending into the Inferior Vena Cava in Comparison to Clear Cell Subtype:Single-Center Experience 2012/05/22
119.	Favorable Impact of Routine Screening of kidneys on the Overall Survival of Patients with Renal Cell Carcinoma Associated with End Stage Renal Disease under Chronic Dialysis Therapy 2012/05/21
120.	Predictors for Postoperative Renal Function after Partial Nephrectomy-Including Postoperative Biomarkers 2012/05/21
121.	Renal Cell Carcinoma(RCC) in Patients with End-stage Renal Disease: Does it really exhibit favorable prognosis compared to sporadic RCC? 2012/05/20
122.	MRI detectability of cancer in the anterior compartment of the prostate: three-dimensional comparison with radical prostatectomy specimen 2012/03/01
123.	Correlation between the Changes in the EPIC QOL Score and the DVH Parameters in High Dose Rate Brachytherapy combined with Hypofractionated EBRT for Prostate Cancer 2011/10/02
124.	Incidence of lymph node involvement according to pathological T stage or tumor grade in the urothelial carcinoma of the upper urinary tract 2011/08/13
125.	Prognosis and characteristics of renal cell carcinoma in hemodialysis patients-Comparison between unilateral and bilateral occurrence 2011/08/13
126.	The increased utilization of partial nephrectomy for patients with renal cell carcinoma with the normal contralateral kidney-the influence of tumor size on the choice surgical procedure in this expert single center 2011/05/16
127.	No inpact of tumor location on the residual renal function after nephron-sparing surgery in the patients with renal tumors 2010/11
128.	Renal cell carcinoma(RCC) in patients with autosomal dominant polycystic kidney diesease(ADPKD) 2010/11
129.	Greater impact of lymphadenectomy according to the regional node template on the survival of patients with urothelial carcinoma of the upper urinary tract-a comparison between the template and the total number of lymph nodes removed 2010/05
130.	No impact of tumor location on the residual renal funtion after nephron-sparing surgery in the patients with renal tumors 2010/05
Display 5 items
Display all(130)

■ Education

1991/04～1997/03

Faculty of Medicine, Asahikawa Medical College, Graduated, Docter of Medicine